Infection-mediated preterm birth: Bacterial origins and avenues for intervention

Research output: Contribution to journalReview article

Abstract

Preterm birth (PTB) is globally the leading cause of death and disability in children under five years of age. Intra-amniotic infection is well recognised as a major cause of PTB. Importantly, it is the most common cause of extreme PTB (birth prior to 28 weeks gestation), which is frequently associated with a wide range of serious neonatal morbidities. Recent developments in next generation sequencing technologies, combined with many years of culture-based microbiological data have allowed us to gain a deeper understanding of the pathogenesis of infection-mediated PTB. In particular, studies have revealed numerous potential routes to intra-amniotic infection beyond the classically described ascending vaginal route. Currently, antibiotic therapy is standard treatment for suspected or confirmed intra-amniotic infection, although its use in this context has had mixed success due to problems ranging from inappropriate antibiotic selection in relation to the target organism/s, to poor transplacental drug passage. In this review, we will draw together evidence from animal models and human studies to characterise pathways to intra-amniotic infection. We will then thoroughly outline current therapeutic protocols for cases of intra-amniotic infection and suggest potential new avenues for treatment.

Original languageEnglish
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
DOIs
Publication statusPublished - Dec 2019

Fingerprint

Premature Birth
Infection
Anti-Bacterial Agents
Therapeutics
Cause of Death
Animal Models
Parturition
Technology
Morbidity
Pregnancy
Pharmaceutical Preparations

Cite this

@article{1663537a71854ce09db7ac363561874f,
title = "Infection-mediated preterm birth: Bacterial origins and avenues for intervention",
abstract = "Preterm birth (PTB) is globally the leading cause of death and disability in children under five years of age. Intra-amniotic infection is well recognised as a major cause of PTB. Importantly, it is the most common cause of extreme PTB (birth prior to 28 weeks gestation), which is frequently associated with a wide range of serious neonatal morbidities. Recent developments in next generation sequencing technologies, combined with many years of culture-based microbiological data have allowed us to gain a deeper understanding of the pathogenesis of infection-mediated PTB. In particular, studies have revealed numerous potential routes to intra-amniotic infection beyond the classically described ascending vaginal route. Currently, antibiotic therapy is standard treatment for suspected or confirmed intra-amniotic infection, although its use in this context has had mixed success due to problems ranging from inappropriate antibiotic selection in relation to the target organism/s, to poor transplacental drug passage. In this review, we will draw together evidence from animal models and human studies to characterise pathways to intra-amniotic infection. We will then thoroughly outline current therapeutic protocols for cases of intra-amniotic infection and suggest potential new avenues for treatment.",
keywords = "anti-inflammatory drugs, antibiotics, bacteriophage, intra-amniotic infection, preterm birth",
author = "Stinson, {Lisa F.} and Payne, {Matthew S.}",
year = "2019",
month = "12",
doi = "10.1111/ajo.13078",
language = "English",
journal = "The Australian and New Zealand Journal of Obstetrics and Gynaecology",
issn = "0004-8666",
publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - Infection-mediated preterm birth

T2 - Bacterial origins and avenues for intervention

AU - Stinson, Lisa F.

AU - Payne, Matthew S.

PY - 2019/12

Y1 - 2019/12

N2 - Preterm birth (PTB) is globally the leading cause of death and disability in children under five years of age. Intra-amniotic infection is well recognised as a major cause of PTB. Importantly, it is the most common cause of extreme PTB (birth prior to 28 weeks gestation), which is frequently associated with a wide range of serious neonatal morbidities. Recent developments in next generation sequencing technologies, combined with many years of culture-based microbiological data have allowed us to gain a deeper understanding of the pathogenesis of infection-mediated PTB. In particular, studies have revealed numerous potential routes to intra-amniotic infection beyond the classically described ascending vaginal route. Currently, antibiotic therapy is standard treatment for suspected or confirmed intra-amniotic infection, although its use in this context has had mixed success due to problems ranging from inappropriate antibiotic selection in relation to the target organism/s, to poor transplacental drug passage. In this review, we will draw together evidence from animal models and human studies to characterise pathways to intra-amniotic infection. We will then thoroughly outline current therapeutic protocols for cases of intra-amniotic infection and suggest potential new avenues for treatment.

AB - Preterm birth (PTB) is globally the leading cause of death and disability in children under five years of age. Intra-amniotic infection is well recognised as a major cause of PTB. Importantly, it is the most common cause of extreme PTB (birth prior to 28 weeks gestation), which is frequently associated with a wide range of serious neonatal morbidities. Recent developments in next generation sequencing technologies, combined with many years of culture-based microbiological data have allowed us to gain a deeper understanding of the pathogenesis of infection-mediated PTB. In particular, studies have revealed numerous potential routes to intra-amniotic infection beyond the classically described ascending vaginal route. Currently, antibiotic therapy is standard treatment for suspected or confirmed intra-amniotic infection, although its use in this context has had mixed success due to problems ranging from inappropriate antibiotic selection in relation to the target organism/s, to poor transplacental drug passage. In this review, we will draw together evidence from animal models and human studies to characterise pathways to intra-amniotic infection. We will then thoroughly outline current therapeutic protocols for cases of intra-amniotic infection and suggest potential new avenues for treatment.

KW - anti-inflammatory drugs

KW - antibiotics

KW - bacteriophage

KW - intra-amniotic infection

KW - preterm birth

UR - http://www.scopus.com/inward/record.url?scp=85074437620&partnerID=8YFLogxK

U2 - 10.1111/ajo.13078

DO - 10.1111/ajo.13078

M3 - Review article

JO - The Australian and New Zealand Journal of Obstetrics and Gynaecology

JF - The Australian and New Zealand Journal of Obstetrics and Gynaecology

SN - 0004-8666

ER -